MedPage Today2h
Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
Bob Gale says goodbye to ‘Back to the Future 4′ in a blunt way: “F**k you”
The co-creator and screenwriter of the 'Back to the Future' trilogy has been very outspoken about the possibility of a fourth ...
Back To The Future screenwriter has brutal statement to fans begging for sequel
A screenwriter for Back to the Future issued a savage response after being questioned on a possible fourth sequel. The sci-fi ...
FOX8 Cleveland5h
Conductor Daniel Barenboim says he’s been diagnosed with Parkinson’s disease
Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...
Gain Therapeutics, Inc.: Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...
‘Back To The Future 4’ will never happen, says writer Bob Gale
The writer of Back To The Future, Bob Gale, has given a blunt reaction to the idea of there ever being a fourth film.
manilatimes9h
Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...